RETRACTED ARTICLE: BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors
Abstract Gastrointestinal stromal tumors (GISTs) are primarily characterized by activating mutations of tyrosine kinase or platelet-derived growth factor receptor alpha. Although the revolutionary therapeutic outcomes of imatinib are well known, the long-term benefits of imatinib are still unclear....
Saved in:
| Main Authors: | Jianfeng Mu, Xuezeng Sun, Zhipeng Zhao, Hao Sun, Pengda Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2021-10-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-021-04186-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retraction Note: BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors
by: Jianfeng Mu, et al.
Published: (2025-06-01) -
Retraction Note to: BRD4 promotes tumor progression and NF-κB/CCL2-dependent tumor-associated macrophage recruitment in GIST
by: Jianfeng Mu, et al.
Published: (2025-03-01) -
Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib
by: Akira Sawaki, et al.
Published: (2014-01-01) -
The effect of ubiquitination and deubiquitination to imatinib resistance in gastrointestinal stromal tumors
by: Huade Huo, et al.
Published: (2025-07-01) -
RNA profiling and immunohistochemistry analyses of circRNAs in imatinib-resistant gastrointestinal stromal tumors
by: Hanxing Tong, et al.
Published: (2025-05-01)